Is this your firm? Get featured or correct your listing →
Strategy
Geographies
NYC
Funds
2| Fund | Vintage | Size | Strategy | Source |
|---|---|---|---|---|
| Oncology Ventures Fund II | 2026 | $62M | FlagshipOncology specialist · Early-stage | As of Apr 23, 2026VCWire |
| Oncology Ventures Fund I | 2024 | $30M | Flagship | As of 2024Value Add VC funds tracker |
Portfolio companies listed on Oncology Ventures' website
23 listed- Biomakers
- Cancernavigatorcancernavigator.com
- Colla Healthcollahealth.com
- Concr
- Daymark Health
- Everhopeeverhope.care
- FidoCure
- Gabbi
- Health Universe
- IgniteData
- Kadancekadance.com
- Lumonous
- Modmodicusprime.com
- mPath
- Nexcurenexcure.com
- OncoveryCare
- Reimagine Care
- RISA
- Stitchstitchhealth.co
- Toño
- Traversal Healthtraversalhealth.com
- Triomicstriomics.com
- Well-beamwell-beam.com
Source: Oncology Ventures portfolio page, as of Oct 13, 2026. The firm's site may list more.
Oncology Ventures FAQ
What is Oncology Ventures' latest fund?
Oncology Ventures Fund II, closed at $62M (As of Apr 23, 2026; VCWire).
How large are Oncology Ventures' funds?
Oncology Ventures funds Value Add tracks include Oncology Ventures Fund II ($62M, 2026); Oncology Ventures Fund I ($30M, 2024), out of 2 Oncology Ventures funds tracked in total.
Sources & methodologyshow
Where these figures come from
- Value Add VC funds trackerValue Add VC data1 fact
- VCWireValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.